Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...

Biological Causes of Schizophrenia

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.

Mutations

Mutations

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bringing the 4Ms Home: Elevating the Role of Nonmedical Home Care in Age-Friendly Health Systems.

Journal of gerontological nursing·2025

Same author

Neuroanatomical Correlates of Negative Symptoms in Schizophrenia.

bioRxiv : the preprint server for biology·2025

Same author

Genome topology analysis and transcriptomics of human osteoclasts reveals enhancer-promoter interactions at loci for bone traits and diseases.

JBMR plus·2025

Same author

Evaluating antibiosis resistance to cabbage aphid (Brevicoryne brassicae L., 1758) in vegetable brassicas (Brassica oleracea L.) and related C-genome brassica species.

Pest management science·2025

Same author

All pain, no gain: porokeratosis ptychotropica remains a therapeutic challenge.

Clinical and experimental dermatology·2025

Same author

Chromoblastomycosis: a contemporary review of a neglected disease.

Clinical and experimental dermatology·2025

Search research articles

Related Experiment Video

Updated: May 23, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

Deleterious GRM1 mutations in schizophrenia.

Mohammed Akli Ayoub¹, Dora Angelicheva, David Vile

¹Western Australian Institute for Medical Research/UWA Centre for Medical Research, University of Western Australia, Perth, Australia.

|March 27, 2012

Summary

This summary is machine-generated.

Rare GRM1 gene variants may contribute to various psychiatric conditions. Deleterious mutations in metabotropic glutamate receptor 1 (mGluR1) were found in schizophrenia patients and their families, impacting receptor function.

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Related Experiment Videos

Last Updated: May 23, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Area of Science:

Neuroscience
Genetics
Psychiatry

Background:

The GRM1 gene encodes metabotropic glutamate receptor 1 (mGluR1), a key modulator of neuronal signaling and synaptic plasticity.
Previous research identified deleterious nsSNPs in GRM1 in patients with schizophrenia and bipolar disorder.
GRM1 is a plausible candidate gene for schizophrenia due to its functional role.

Purpose of the Study:

To investigate rare non-synonymous single nucleotide polymorphisms (nsSNPs) in the GRM1 gene in schizophrenia patients.
To analyze the functional effects and family segregation of GRM1 variants.
To explore the potential contribution of mGluR1 to diverse psychiatric conditions.

Main Methods:

Sanger sequencing of GRM1 coding regions in 450 schizophrenia patients and 605 controls.
In-vitro functional assays to assess the impact of nsSNPs on mGluR1 signaling (inositol phosphate production) and cell membrane expression.
Family segregation analysis to determine inheritance patterns of deleterious nsSNPs.

Main Results:

Identical numbers of nsSNPs were found in cases and controls, but case-specific nsSNPs were more likely to be predicted as deleterious (6/6 vs 1/6).
In-vitro studies confirmed impaired function for 4/6 case-specific mutants, with reduced inositol phosphate production.
Family studies revealed that deleterious nsSNPs were inherited and present in relatives with various neuropsychiatric conditions, including schizophrenia, depression, anxiety, substance dependence, and epilepsy.

Conclusions:

Deleterious GRM1 nsSNPs, particularly those affecting mGluR1 function, may contribute to schizophrenia and other psychiatric disorders.
The findings support a modulatory role of mGluR1 in a spectrum of neuropsychiatric conditions.
GRM1 variants represent a potential genetic factor influencing diverse psychiatric phenotypes.